Abstract: Adeno-associated virus type 2 is known to inhibit replication of herpes simplex virus 1 (HSV-1). This activity has been linked to the helicase-and DNA-binding domains of the Rep68/Rep78 proteins. Here, we show that Rep68 can bind to consensus Rep-binding sites on the HSV-1 genome and that the Rep helicase activity can inhibit replication of any DNA if binding is facilitated. Therefore, we hypothesize that inhibition of HSV-1 replication involves direct binding of Rep68/Rep78 to the HSV-1 genome. DOI: https://doi.org/10.1128/JVI. Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-113456 Accepted Version Originally published at: Seyffert, Michael; Glauser, Daniel L; Tobler, Kurt; Georgiev, Oleg; Vogel, Rebecca; Vogt, Bernd; Agundez, Leticia; Linden, Michael; Büning, Hildegard; Ackermann, Mathias; Fraefel, Cornel (2015). Adenoassociated virus type 2 Rep68 can bind to consensus rep-binding sites on the herpes simplex virus 1 genome. Journal of Virology, 89 (21) The ITRs form hairpin structures and contain a Rep-binding site (RBS) and a terminal 43 resolution site (trs), which together act as viral origin of DNA replication (6, 7). The cap gene 44 is transcribed from the p40 promoter and encodes the capsid proteins VP1, VP2, and VP3, 45 which differ in their N-termini due to alternative start codons (8, 9). In addition, a nested 46 open-reading frame (ORF) within the cap gene encodes a protein designated assembly-47 activating protein (AAP), which is believed to be required for AAV2 capsid assembly in the 48 nucleolus (10, 11). The rep gene encodes the Rep proteins, which are synthesized in four 49 different forms due to transcription from two different promoters, p5 and p19, and alternative 50 splicing of an intron near the C-terminal end (12). The different Rep proteins are termed 51 Rep40, Rep52, Rep68, and Rep78 according to their apparent molecular weight. The Rep 52 proteins are involved in diverse processes during the viral life cycle, such as DNA replication, 53 regulation of gene expression, genome packaging, and site-specific genomic integration (13-54 18). 55 HSV-1 belongs to the subfamily of the Alphaherpesvirinae and is the reagent causing 56 mucosal eruptions at the site of infections, which can reoccur at the same site upon 57 reactivation from latency (19, 20). The HSV-1 virion is built up by three structural 58 components which are the capsid, the tegument and the surrounding envelope. The viral 59 genome is a linear double stranded DNA molecule of 152 kb in size and has a unique 60 structure. It is divided into two covalently joined segments, which contains unique segments 61 (U L , U S ) and inverted repeat regions (TR L , IR L , IR S , and TR S ). The IR sequences link the L 62 4 and S segments (Fig. 1A) . HSV-1 gene expression and replication occurs in a temporally 63 regulated cascade; immediate early (IE), early (E) and late (L). IE proteins mainly exhibit 64 regulatory functions and initiate expression of the E genes. The E proteins comprise 65 enzymes necessary for viral DNA replication and are therefore required for the expression of 66 some of the L genes, as expression of these genes relies on DNA replication. All viral 67 replication events take place in the nucleus within distinct areas termed replication 68 compartments (RCs) (21). In the course of viral DNA replication, these RCs grow 69 continuously and four different stages (I-IV) can be distinguished according to RCs staining 70 patterns (22-24). The minimal set of HSV-1 proteins required for initiating AAV2 replication 71 consists of the E proteins UL5, UL8, and UL52, which together form the HSV-1 72 helicase/primase complex, as well as the ssDNA binding protein ICP8 (UL29) (25)(26)(27). In 73 addition, the HSV-1 IE proteins ICP4 and ICP0, the E protein complex forming the HSV-1 74 polymerase (UL30 and UL42) and the US1 gene product, strongly enhance AAV2 replication 75 (26). AAV2 has developed strategies to inhibit helper virus replication, likely to reduce 76 competition (24,(28)(29)(30)(31)(32)(33). For example, expression of the AAV2 non-structural proteins 77
FINDINGS 35
Adeno-associated virus type-2 (AAV2) is a nonpathogenic human parvovirus with a unique 36 biphasic life cycle. In the absence of a helper virus, AAV2 establishes a latent infection while 37 in the presence of a helper virus, such as adenovirus type-2 (AdV2), herpes simplex virus 38 type-1 (HSV-1) or human papillomavirus type-16 (HPV-16), it undergoes lytic replication (1-39 4). The AAV2 genome is a single-stranded (ss) DNA of 4,680 nucleotides, which is packaged 40 into an icosahedral capsid with a diameter of approximately 20 nm (5). The genome harbors 41 two clusters of genes, rep and cap, which are flanked by inverted terminal repeats (ITRs). 42
The ITRs form hairpin structures and contain a Rep-binding site (RBS) and a terminal 43 resolution site (trs), which together act as viral origin of DNA replication (6, 7). The cap gene 44 is transcribed from the p40 promoter and encodes the capsid proteins VP1, VP2, and VP3, 45 which differ in their N-termini due to alternative start codons (8, 9). In addition, a nested 46 open-reading frame (ORF) within the cap gene encodes a protein designated assembly-47 possibly due to the different oligomerization states Rep68 can form on ds DNA templates 118 (36) (37) (38) . To confirm that binding of His-Rep68 to the pRBS is indeed specific, we performed 119 EMSAs as described above, except that 5 fmol of non-labeled (cold) duplex ITR 120 oligonucleotide was used as competitor. The cold ITR competitor DNA appeared to prevent 121 binding of His-Rep68 to the pRBS oligonucleotides, as no shift was observed under these 122 conditions for the oligonucleotides No. 1-3 and a clearly reduced shift for the oligonucleotides 123
No. 4-5 (Fig. 2B) . 124
In order to investigate whether AAV2 Rep68 is able to bind to consensus RBS on the HSV-1 125 genome also in HSV-1 infected cells, we performed chromatin-immunoprecipitation (ChIP) 126 assays followed by quantitative (q)PCR analysis (ChIP-qPCR). For this, Vero cells were 127 transfected with plasmids expressing either Rep68, or Rep52 proteins fused with enhanced 128 green fluorescent protein (EGFP). The next day, the cells were infected with wt HSV-1 (strain 129 F) at an MOI of 40. At 16 h after infection, the cells were fixed with 4% paraformaldehyde 130 (PFA), sonicated for 10min and processed for ChIP using the GFP-Trap ® kit (Chromotek). 131
The immunoprecipitated DNA oligonucleotides were then analyzed by qPCR using primers 132 specific for the consensus RBS No. 1-9 ( Fig. 1 15sec, 60°C for 1min) followed by a final elongation step at 95°C for 10min. The raw Ct 138 values were analyzed using the percent input (%-INPUT) method (%-INPUT = 100*2 ΔCt , 139
For each primer pair 140 tested (no RBS and putative RBS 1-9), the %-INPUT values were calculated from cells 141 expressing either Rep52-GFP (light grey bars) or Rep68-GFP (dark grey bars) (Fig. 2C) .
To address the first point, we calculated the difference between each value obtained from 145 binding of Rep68-GFP to a pRBS and the control value (no RBS) which was set as 1. The 146 graph in Fig. 2D shows that Rep68-GFP can bind more efficiently to the HSV-1 DNA that 147 harbours a pRBS than to the control with no pRBS, with one exception; binding to pRBS No. 148 7 was not more efficient than binding to the control with no pRBS, likely because the pRBS 149
No. 7 consensus sequence is slightly aberrant (Fig. 1B) . Nevertheless, we can conclude that 150 binding of Rep68 to HSV-1 DNA is more efficient when it harbors a pRBS. To address the 151 second point, we calculated the difference (%-INPUT ratio) between the Rep68-GFP and the 152 Rep52-GFP values for each consensus binding site No. 1-9 and the negative control (no 153 RBS). The ratios were normalized to the no RBS (US1) control ratio and are shown in Fig.  154 2D. As expected, the ratio between Rep68-GFP and Rep52-GFP was the smallest in the 155 absence of a consensus RBS (no RBS) and was set as 1. The ratios for all pRBS No. 1-9 156
were clearly higher and were statistically significant for pRBS No. 3-8. We can therefore 157 conclude that the DNA-binding domain of Rep68 enhances binding to pRBS in this assay. To 158 appreciate the quality of the binding of Rep68 to pRBS, we tested binding of a HSV-1 DNA 159 binding protein, ICP4, to the ICP4-binding site in the HSV-1 ICP0 promoter relative to an 160 unspecific DNA that does not contain an ICP4 binding site (US1). For this, we infected Vero 161 cells with a recombinant HSV-1 (rHSVEYFP-ICP4) which expresses the ICP4 protein fused 162 to the enhanced yellow fluorescent protein (EYFP) (39). One day later, we processed the 163 cells for ChIP and qPCR as described above. We found that the ICP4 protein binds 164 specifically to the ICP0 promoter. Binding efficiency was approximately 2.5-fold higher to the 165 ICP0 promoter sequence than to the US1 control sequence (Fig. 2F) and is comparable to 166 previous findings (40). We can therefore conclude that binding of AAV2 Rep68 to the HSV-1 167 DNA at a pRBS is at least as efficient as binding of the native HSV-1 DNA-binding protein 168 ICP4 to its binding site in the HSV-1 ICP0 promoter (Fig. 2F) . (Fig. 3C, panel a) , Rep40/52 (Fig. 3C,  196 panel f) and Rep40/52K340H-LacI (Fig. 3C, panel p) . We confirmed that Rep40/52-LacI 197 proteins indeed bind to LacI-repressor binding sites on the pHSV-lacO reporter DNA by 198 determining the degree of colocalization of the LacI-EYFP and the Rep AF594 signals in the 199 merged images of panels l-n and q-s (Fig. 3E) was comparable in cells transfected with the Rep40/52 (Fig. 3C , panels f-i) and the 205 Rep40/52K340H-LacI (Fig. 3C, panels p-s) transfected with Rep40/52-LacI (Fig. 3C, panel o) or the helicase mutant Rep40/52K340H-213 LacI (Fig. 3C, panel t) respectively. Such foci were not observed when cells were transfected 214 with the Rep40/52 (Fig. 3C, panel j) encoding plasmid or the empty backbone plasmid 215 pcDNA3.1+ (Fig. 3C, panel e) . Some of the foci represent background binding of EYFP-LacI 216 to Lac-repressor binding sites on the pHSV-lacO input plasmid because foci were observed 217 also in presence of pHSV-lacO and EYFP-LacI and absence of helpervirus (not shown). This 218 hypothesis is supported also by the fact that Rep52-LacI proteins, which can also bind to the 219 Lac-repressor binding sites on the pHSV-lacO replicons, co-localized with the numerous 220 EYFP-LacI foci (Fig. 3C, insets panel o 
